Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07345416

A Clinical Trial Assessing the Efficacy and Safety of ST-1 Silicone Hydrogel Daily Disposable Soft Contact Lenses Compared to Miru 1day UpSide

A Randomized, Single-Masked, Active-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of ST-1 Silicone Hydrogel Daily Disposable Soft Contact Lenses Compared to Miru 1day UpSide

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
63 (estimated)
Sponsor
Menicon Co., Ltd. · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study will enroll 63 eligible subjects (126 eligible eyes, complete at least 108 evaluable eyes) in approximately 6 different medical centers in Taiwan, in order to evaluate the efficacy and safety of ST-1 silicone hydrogel daily disposable soft contact lenses (ST-1 lenses) compared to Miru 1day UpSide. Enrolled subjects will be randomized in a 2:1 test to control ratio at Visit 1. Each site will enroll 8 (intended minimum) to 12 (intended maximum) subjects. In order to eliminate the bias, the Investigators and the evaluators will be masked to the treatment assignment of the randomization code. During the study, the Investigator(s) will examine the ocular health via inquiry, slit lamp biomicroscopy (SLB), visual acuity (VA) test, keratometry, and refractive changes. The Investigator(s) will check ocular health and evaluate the inclusion/exclusion criteria of subjects at screening. After entering the study, subjects will be required to wear the lenses on a daily basis, record daily wearing time on a diary, return to the study site at scheduled visits for evaluations and complete the self-assessment questionnaire at Visit 2 to Visit 7 (1 day, 1 week, 2 weeks, 1 month, 2 months, 3 months).

Conditions

Interventions

TypeNameDescription
DEVICEST-1ST-1 lens worn in daily wear, daily disposable mode.
DEVICEMiru 1day UpSideMiru 1day UpSide lens worn in daily wear, daily disposable mode.

Timeline

Start date
2026-05-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-01-15
Last updated
2026-01-15

Locations

6 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07345416. Inclusion in this directory is not an endorsement.